Virgin Galactic (SPCE) Competitors

Clover Health Investments (NASDAQ:CLOV) and Virgin Galactic (NYSE:SPCE) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

Does the media prefer CLOV or SPCE?

In the previous week, Virgin Galactic had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 4 mentions for Virgin Galactic and 2 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.88 beat Virgin Galactic's score of -0.16 indicating that Clover Health Investments is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Virgin Galactic	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher valuation & earnings, CLOV or SPCE?

Clover Health Investments has higher revenue and earnings than Virgin Galactic. Clover Health Investments is trading at a lower price-to-earnings ratio than Virgin Galactic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.37B	1.02	-$43.01M	-$0.08	-34.13
Virgin Galactic	$7.04M	25.56	-$346.74M	-$9.04	-0.35

Is CLOV or SPCE more profitable?

Clover Health Investments has a net margin of -2.68% compared to Virgin Galactic's net margin of -17,828.03%. Clover Health Investments' return on equity of -12.20% beat Virgin Galactic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-2.68%	-12.20%	-6.95%
Virgin Galactic	-17,828.03%	-98.94%	-32.03%

Do analysts rate CLOV or SPCE?

Clover Health Investments presently has a consensus target price of $4.37, suggesting a potential upside of 59.95%. Virgin Galactic has a consensus target price of $4.81, suggesting a potential upside of 54.00%. Given Clover Health Investments' stronger consensus rating and higher possible upside, research analysts plainly believe Clover Health Investments is more favorable than Virgin Galactic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Virgin Galactic	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk and volatility, CLOV or SPCE?

Clover Health Investments has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, Virgin Galactic has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of CLOV or SPCE?

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 46.6% of Virgin Galactic shares are owned by institutional investors. 24.1% of Clover Health Investments shares are owned by insiders. Comparatively, 0.3% of Virgin Galactic shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Clover Health Investments beats Virgin Galactic on 11 of the 16 factors compared between the two stocks.